Evaxion A/S American Depositary Share (EVAX)

• Market cap: $18.6M
• 1 day: 2.08%
• 5 days: -2%
• 1 month: 3.16%
• 3 months: -1.01%
• 6 months: 58.06%
• Year to date: -36.36%
• 1 year: -80.78%
• 5 years: -99.41%
• 10 years: -99.41%
• Sector: Healthcare
• Industry: Biotechnology

About: Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Employees: 46

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

31% more capital invested

Capital invested by funds: $2.5M [Q1] → $3.27M (+$768K) [Q2]

20.69% more ownership

Funds ownership: 0.43% [Q1] → 21.12% (+20.69%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

20% less funds holding

Funds holding: 10 [Q1] → 8 (-2) [Q2]

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2